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A distinguishing characteristic of experimental fever is the development of 
tolerance to repeated injections of a pyrogenic agent. Tolerance to endotoxins 
has been the subject of extensive study (1-5). This phenomenon may  be clearly 
dissociated from the classical immune response by its rapid onset, relatively 
short  duration, non-specificity and lack of  correlation with serum  antibody 
levels. Crucial evidence for the difference is the observation that patients with 
agammaglobulinemia acquire  tolerance  to serial injections of endotoxin in a 
normal fashion (6). 
In several respects, tolerance to the pyrogenic effects of the various viruses 
in the influenza group resembles that occurring with endotoxins. It is also rela- 
tively non-specific, with the injection of one virus conferring a certain degree of 
cross-tolerance to other viruses in the same group. Virus tolerance likewise can- 
not be correlated with serum antibody levels and is of brief duration: approxi- 
mately 11 days as compared with 3 weeks in the case of endotoxins (7). 
However, certain striking differences in these  two types of tolerance have 
been described. Tolerance to a  constant dose of endotoxin is never complete 
despite repeated injections; with certain viruses, on the other hand, tolerance 
may be complete on the 2nd or 3rd day of injection. In addition, cross-tolerance 
between endotoxins and virus has not been demonstrated. Finally, tolerance to 
virus is not reversible by injection of thorotrast. These differences have led to 
the conclusion that tolerance to endotoxin and viruses are produced by different 
mechanisms (7). 
The first paper in this series  (8) has described the presence of a circulating 
endogenous pyrogen in rabbits made febrile by intravenous injection of either 
PR8 strain of influenza A or Newcastle disease virus (NDV). It has been postu- 
lated  that  the  release of an endogenous pyrogen is  an essential step  in the 
pathogenesis of fever with these two viruses. Evidence to be presented here indi- 
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cates that circulating endogenous pyrogen also plays an important role in the 
development of virus-tolerance. The demonstration of cross-tolerance between 
virus  and  endotoxin  suggests further  that  endogenous pyrogen occurring in 
these two forms of experimental fever may be similar. 
Methods 
GeneraL--The preparation and  titration of Newcastle disease virus (NDV) and  PR8 
strain of influenza virus have been described (8). Methods of determining circulating endog- 
enous pyrogen after the inoculation of virus into rabbits were performed as outlined in the 
preceding papers of this series (8, 9). 
Infectivity Titration.--lO- or ll-day-old embryos were inoculated with serial tenfold dilu- 
tions of each serum sample as outlined previously (8). After incubation of embryos at 35°C. 
for 44 to 48 hours, the allantoic fluids were harvested and the presence of hemagglutinin was 
determined. The LDs0 was calculated according to the method of Reed and Muench (10). 
Immune Serum.--Techniques  both for immunizing rabbits with NDV and for the determi- 
nation of serum antibody were performed as previously described (9). 
Typhoid Vaccine.--A single lot was used, monovalent reference standard  NRV-LS No. 
1, made from Salmonella typhosa V-58) Pyrogen tolerance was induced by a series of at least 
seven daily injections of 1.5 ml. of a 1:10 dilution of the stock vaccine (11). 
RESULTS 
Correlation of Tolerance and Production  of Endogenous  Pyrogen.--The devel- 
opment of tolerance to a  course of injections with NDV (either 4 or 1 ml.) is 
characterized by a progressive decrease in the height and duration of fever. The 
second peak generally disappears  on the  2nd day and  there  is  a  progressive 
diminution of the first peak with  subsequent injections.  Complete tolerance, 
e.g. the absence of a febrile response, has not been demonstrated, however, with 
a  course of 1 ml. NDV over a  period of 1 week or more.  Characteristically, a 
minimal response develops by about the 4th day which persists throughout the 
period of observation. 
It was of interest to determine whether these characteristic features of devel- 
oping tolerance were accompanied by comparable changes in the level of circu- 
lating  transferable  endogenous pyrogen. 
Fig. 1 demonstrates the average fever curves of a group of rabbits on the 1st, 
2nd, and 3rd day of daily injections with 4 ml. NDV. Beneath each donor curve, 
levels of transferable endogenous pyrogen are plotted at various intervals after 
inoculation of the  donors with virus.  The amount of circulating endogenous 
pyrogen was  determined  for each  interval  by calculation  of  the  mean fever 
index induced by the particular serum in a  group of  normal  recipients. 
It is apparent that the progressive decline in the febrile response to virus from 
the 1st to the 3rd day was associated with a similar dimi/mtion in transferable 
endogenous pyrogen. As early as the 2nd day, a  significant amount of endog- 
a Obtained from the Army Medical Service Graduate School, Walter Reed Medical Center. 
This vaccine had a bacterial count of approximately 500 million per ml.  (11). ELISHA  ATKINS  AND  WEI  C.  HUANG  417 
enous pyrogen was only obtainable at the 3rd  hour,  consistent with  the con- 
sidemble but brief fever occurring in the donors.  By the 3rd  day,  there was 
virtually no detectable endogenous pyrogen at any of the intervals tested. 
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FIo. 1. Mean febrile responses of 4 animals given successive  daily injections of 4 ml. NDV. 
The titer of circulating endogenous  pyrogen at various intervals after inoculation on each day 
was calculated by passive transfer of 15 ml. sera to normal recipients (indicated by numbers 
in parentheses). F.I., fever index; R,  recipients. 
A  similar experiment was designed with the PR8 virus. As contrasted with 
NDV, tolerance is complete by the 2nd day with this virus. Donors reinjected 
with PR8 on the 2nd day remained afebrile and were bled at 4 hours.  There was 
no transferable endogenous pyrogen (8). 
These two experiments indicate that the development of tolerance to reinjec- 
tion of either PR8 or NDV is closely correlated with corresponding changes in 
the circulating levels of endogenous pyrogen. 418  PATtIOGEN~ESIS OF  I~EVER. III 
Modification of Virus Fever by in Vitro Incubation of NDV with Serum from 
Normal,  Tolerant, and Immune Animals.--Fever resulting from injections of 
endotoxins can be markedly modified by in vitro incubation of the pyrogens 
with sera from either normal or tolerant animals (4, 5, 12-15).  Serum  factors 
have been implicated in the development  of tolerance to these agents. It was of 
interest, therefore,  to determine whether the pyrogenicity of NDV  would  be 
similarly  altered  after incubation in vitro with sera from animals tolerant to 
virus. 
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FIO. 2. Febrile responses of normal recipients given an injection of 1 ml. NDV after incuba- 
tion with various sera. Average values for 3 to 6 recipients are shown. 
One ml. of NDV was added to each 5 ml. of pooled sera from the following sources:  (a) 
Rabbits given 4  ml. of NDV 24 hours earlier and hence designated as "virus-tolerant", (b) 
Rabbits given an 8 day course of injections of 1.5 ml. 1:10 dilution of typhoid vaccine and 
thus rendered "pyrogen-tolerant"  (see  Methods);  (c)  Rabbits immunized with a  course of 
injections of NDV  (see Methods); (d)  Normal rabbits which had received no injections of 
any kind. After 1 hour incubation at 37°C., the various NDV-sera combinations were given 
in individual injections of 6 ml., containing 1 ml. of NDV, to groups of 3 to 6 recipients. 
The complete inhibition  of the pyrogenic effect of the virus by in vitro incu- 
bation with homologous immune sera  was confirmed  (16). However,  neither 
the normal nor the tolerant sera modified the pyrogenicity of the virus (see 
Fig. 2). The decreased production of endogenous pyrogen occurring with rein- 
jection of virus cannot be attributed to  the development  of serum inhibitors 
to virus per se. 
Clearance of Viremia  Follmeing Injection  of PR8 Virus.--The development 
of tolerance to endotoxins has been correlated with the accelerated clearance of ELISHA  ATKINS  AND  WEI  C.  HUANG  419 
these substances from the circulation by cells of the reticuloendothelial  system 
(2). An experiment was designed to determine whether tolerance  to virus was 
similarly associated with an enhanced removal of circulating  virus. 
Two normal animals were injected with I  ml. PR8 virus. The anim~is were then bled by 
cardiac puncture at 5 and 15 minutes fOllowing the inoculation. Ten nil. blood were obtained 
at each interval with the use of a  syringe moistened with heparin. Tenfold dilutions of each 
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FIG.  3. Titer of circulating virus at various intervals on 1st and 2nd day of inoculation 
with 1 ml. PP,8. Each point represents an average of two determinations. Mean febrile re- 
sponses to the virus on the 2 days are shown in shadowgraphs. 
sample were immediately made in broth and 0.1 ml. of each dilution was inoculated into 10- 
or 11-day-old chick embryos. Infectivity titrations were then performed (see Methods). 
On the 2nd day, the animals were reinjected with 1 ml. PR8 and the procedure repeated. 
In order to obtain comparable data at a later interval, a second experiment was performed 
with another pair of normal rabbits. Each animal was given a  single injection of PR8 on 2 
successive days and bled at 60 minutes. The titer of the virus in the blood on the 2 days of 
the experiment was determined as in the first experiment. 
The results of these two experiments are shown in Fig. 3 and Table I. Despite 
the development of complete tolerance  to the pyrogenic effects of PR8 on the 420  PATIIOGENESIS  OF  FEVER.  III 
2nd  day  (see  shadowgraph  in Fig. 3),  the  clearance of virus from  the blood 
stream was unchanged. 
TABLE I 
Titer of PR8 Virus  (Log IDa) in Whole Blood of Rabbits at  Various lnter~als after 
Intravenous Inoculati~m 
2nd day  1st da  60 mln.  5 rain.  60  rain.  Rabbit No.  5 rain.  15 mln  15 mln. 
9-20  1.22  !.50  --  1.23  1.00  -- 
9-26  1.33  1.00  0--2.4  1.33  1.38 
9-49  --  0.66 
9-59  --  0100  --  --  0.23 
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Fro. 4. Mean fevers of 3 normal rabbits to injections  of 1 ml. NDV on days 1 and 5. Average 
pyrogenic response of 3 recipients to 15 ml. endogenous pyrogen on day 5 after preceding 
virus injection is compared with the mean of 4 normal recipients to same dosage of endogenous 
pyrogen. Note appearance of second fever peak after injection of endogenous pyrogen and 
normal response to virus on day 5 indicating lapse of tolerance. 
Recovery from  Tolerance to  Virus and to Endogenous Pyrogen.--Tolerance  to 
the pyrogenic effect of PR8 virus is lost after a  comparatively brief interval of 
approximately 11  days. Despite high levels  of circulating antibody conferred 
by the initial injection, the fever response at this time is indistinguishable from 
that seen with the first injection (7). ELISHA ATKINS AND  WEI C.  HUANG  421 
An experiment was performed to determine at what time tolerance would disappear to a 
small dose of NDV. Six normal animals were given initial injections of 1 ml. NDV and their 
temperatures recorded. On the 5th day, the injection was repeated in 3 animals, at which time 
they responded with identical fevers indicating that tolerance had lapsed. On the same day, 
the other 3 recipients received injections of 15 ml. endogenous pyrogen. 
All of these animals had normal biphasic febrile responses indicating a  simi- 
lar loss of tolerance to endogenous pyrogen (Fig. 4).  ~ Since the normal febrile 
response to virus and to injected endogenous pyrogen both require the produc- 
tion of endogenous pyrogen, there is an obvious correlation between resumption 
of the  ability to produce endogenous pyrogen to an injection  of endogenous 
TABLE II 
Febrile Responses of Various Types of Recipients to Injection of 15 Ml. Endogenous Pyrogen 
from NDV-Injected Donors 
Monophasic  Biphasic 
A. Single injection on preceding day 
Homologous virus (NDV) 
Heterologous virus (PRS) 
Typhoid vaccine 
Virus or typhoid vaccine plus antipyrine 
Endogenous pyrogen 
B. Course of daily injections 
Virus 
Endogenous pyrogen 
Normal 
Rested for 4 days 
Immune 
Pyrogen-tolerant 
(course of injections of typhoid vaccine) 
Antipyrine only (previous day) 
Epinephrine (previous day) 
pyrogen, as evidenced by the  return  of the  second fever peak,  and recovery 
from tolerance to virus. 
Three recipients immunized to NDV by a course of injections (see Methods) 
and rested for 2 weeks were also found to have normal pyrogenic responses to 
reinjection of either virus or endogenous pyrogen (see Table II). This observa- 
tion supplies further evidence for the correlation between the normal response 
to virus and to endogenous pyrogen and confirms the dissociation previously 
noted between tolerance to virus and classical antibody levels (7). 
Cross-Tolerance  to Endogenous  Pyrogen  after Injection of Heterologous Virus 
or Endotoxin.--Them  is a  considerable degree of cross-tolerance to the pyro- 
genie effects of the various viruses in the influenza group (7). Recipients given 
PR8  virus  have  characteristically  depressed  febrile  responses  to  injection  of 
NDV on the following day (see Fig. 5). 
Tolerance to endogenous pyrogen is characterized by a monophasic fever only, indicating 
the absence of activation of endogenous pyrogen in the recipient (9). 422 
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FIO. 5. Mean febrile responses to 4 mL NDV and 15 ml. endogenous pyrogen before and 
after challenge of recipients with 1 or 2 ml. PR8 virus. Note the loss of the second peak of 
fever indicating tolerance in animals given heterologous virus on the preceding day. Num- 
ber of recipients in each group is shown in parentheses. 
It was of interest to determine, therefore, whether an injection of heterolo- 
gous virus would likewise confer  "tolerance," i.e.,  the  disappearance of  the 
second fever peak, to an injection of endogenous pyrogen from NDV-inoculated 
donors (9). 
Thirteen rabbits were given initial injections of 1 or 2 ml. PR8. On the following  day these 
animals were challenged with 15 ml. of NDV-induced endogenous  pyrogen. They all responded ELISHA ATKINS  AND  WEI  C.  HUANG  423 
with brief monophasic fevers indicating that heterologous virus had rendered the recipients 
tolerant to the injection of endogenous pyrogen (see Fig. 5). 
Another group of 3 recipients was given injections of 2 ml. undiluted typhoid vaccine on 
the day preceding challenge with endogenous pyrogen. The response of these animals was 
also monophasic showing that cross-tolerance to the endogenous pyrogen had similarly been 
established by a single injection of endotoxin (see Fig. 6). The experiment was then reversed 
and  50 hal. endogenous pyrogen from vaccine-injected donors were given to two groups of 
recipients: one normal and  the other injected on the preceding day with 4  ml. NDV. The 
second fever peak, produced by this dose of endotoxin-induced endogenous pyrogen in the 
d 
G~ 
i{D 
'10 
¢.. 
2.0 
1.5 
NDV- Inoculated Donors 
4  Hour Serum 
Recipients 
o  Typhoid  Voccir~e  (Single  injection  or-  24  hours) 
o  Pyrogen- toleront 
*  NDV  {8  doy  course) 
1.0- 
0.5- 
0- 
I  I  I  I  [  I 
0  60  120  180  240  300 
Time  (Minutes) 
FIG. 6. Comparison of mean pyrogenic responses of recipients to 15 ml. endogenous pyro- 
gen. Rabbits were given either single inoculation of typhoid vaccine or course of injections 
with vaccine or NDV. Results are averaged from 3,  10,  and 4  individual responses,  respec- 
tively. 
normal recipients,  8 was suppressed in the recipients given NDV indicating that the injection 
of virus had established a similar type of cross-tolerance (see Fig. 7). 
In a  further experiment, viral-induced endogenous pyrogen was given to a  group of 10 
recipients which  had  been made  tolerant to bacterial pyrogens by a  course  of injections 
of  typhoid vaccine (see  Methods).  These  recipients  had  normal biphasic  responses  when 
challenged on the day following the last of the dally injections of vaccine (see Fig. 6 and 
Table II). 
The endotoxin-tolerant  recipient, unlike the recipient given a  single  previous 
injection of virus or endotoxin,  shows no cross-tolerance to endogenous pyrogen. 
Cross-Tolerance  to Exogenous Pyrogens.--It  has been reported that there  is 
no cross-tolerance to the fever due to virus and endotoxin (7). However, as 
8 In dosages less than 40 ml., endotoxin-induced endogenous pyrogen produced a  mono- 
phasic fever in normal recipients. 424  PATEOGENESIS OF  FEVER. HI 
shown  in  the  preceding paragraph,  a  single  injection of  typhoid  vaccine  or 
virus conferred tolerance (suppression of endogenous pyrogen release and  the 
second fever peak) to an injection of endogenous pyrogen induced by the other 
agent. Since the febrile response to both virus and endotoxin appears to depend 
primarily upon the production of endogenous pyrogen, the injection of either 
one of these exogenous agents should modify the release of endogenous pyrogen 
and hence  the febrile response  to a  subsequent  injection of the other.  Cross- 
tolerance, therefore, should be demonstrable between virus and endotoxin. 
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Fio. 7. Mem-z pyrogenic responses of 5 normal and 4 virus-tolerant recipients to 50 m]. 
endogenous pyrogen pooled from 8 donors which were inoculated with 5 ml. typhoid vaccine 
and bled at 2 hours.  NR,  normal recipient; V-TR, virus-tolerant recipient; "IV, typhoid 
vaccine. 
A group of recipients was given a 3 day course of daily injections of 4 ml. NDV. A second 
group was given a similar course of daily injections with 2 ml. undiluted typhoid vaccine. On 
the 4th day, each group was injected with the opposite agent. The recipients receiving the 
course of NDV were inoculated with 0.05 ml. typhoid vaccine  (0.5 ml. of a  1:10 dilution); 
the typhoid vaccine-injected group, in turn, received 0.5 ml. NDV. 
Two groups of normal recipients were given a single injection of the same dose of either 
vaccine or virus on the 4th day. 
The composite fever curves of each group are plotted in Fig. 8. The recipients 
receiving daily injections of typhoid vaccine were almost completely tolerant 
to NDV.  4 The daily course of NDV was not as effective in conferring tolerance 
to the final injection of typhoid vaccine. However, there was a definite suppres- 
4 In a  similar experiment,  a  single injection of 2 ml. undiluted typhoid vaccine induced 
an almost complete tolerance to 1 ml. PR8 virus on the following day. (Mean fever in 4 vaccine- 
inoculated rabbits: 0.2°C. at 5 hours as opposed to 1.2°C. in 2 controls given virus only.) 425 
2.0- 
sion of the second peak in these animals as compared with the controls. This 
has been shown to be an early feature in the development of tolerance to this 
pyrogen (5). 
Cross-Tolerance to Exogenous Pyrogen after Injection of Endogenous Pyrogen.-- 
The evidence presented so far has shown that exogenous pyrogens produce cir- 
culating endogenous pyrogen and, in addition, confer tolerance to an injection 
of  either  exogenous  or  endogenous  pyrogen.  The  possibility, therefore,  was 
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FIe. 8. Mean responses of recipients to injection of either typhoid vaccine or NDV after 
three daily injections of virus or vaccine,  respectively. Control fevers to the same dosages 
are shown for comparison. Each curve (including controls)  represents average of 5 animals 
to NDV and of 7 animals to vaccine.  Difference between  experimental and control groups 
is significant (pffi  <0.02). 
considered that these effects were mediated by endogenous pyrogen itself and 
that the injection of a  large amount of endogenous pyrogen might, conversely, 
induce tolerance to a  small dose of virus. 
One group of 7 normal rabbits was given individual 50 ml. injections of NDV-induced 
endogenous pyrogen. The following day these animals were  challenged  with 0.1  ml. PR8 
virus (1.0 ml. of a 1:10 dilution). A control group of 3 rabbits received a 50 ml. injection of 
normal serum on the day preceding the inoculation of virus. 
The mean fever curves of these two groups to the virus are shown in Fig. 9. 
The prior injection of a large amount of endogenous pyrogen conferred complete 
tolerance to this dosage of PR8 virus. 426  PATHOGENESIS  OF  FEVER.  HI 
In a second experiment of similar design, 9 rabbits were given 50 ml. injections of endog- 
enous pyrogen followed on the next day with 0.5 ml. NDV. Eleven control recipients were 
given the same dosage of virus after a preliminary injection of 50 rot. non-pyrogenic sera from 
one of the following sources: (a) normal donors (6 recipients),  (b) donors given 4 ml. NDV 
and bled at 30 minutes during the latent period (2 recipients), (¢) donors injected for the 3rd 
successive day with 4 ml. NDV and bled at 4 hours (3 recipients). 
The mean febrile responses of both the experimental  and control groups to 
the injection of virus on the 2nd day of the experiment are also shown in Fig. 9. 
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FzG. 9. Mean fevers produced by injection of either 0.5 ml. NDV or 0.1 ml. PR8 in animals 
receiving preceding  injection  of 50 ml.  endogenous pyrogen.  Controls were given  similar 
dosage of non-pyrogenic sera before inoculation of virus.  Difference between experimental 
and control groups at 5 hours with both viruses is significant (p =  <0.01). 
Since the controls had a remarkably uniform response to virus, regardless of the 
type of sera injected on the preceding day, a  single curve is shown. The group 
which had received  endogenous pyrogen, on the  other hand, had a  depressed 
febrile response to NDV simulating the tolerance which develops to this virus 
on the 2nd day of injection (see Figs. 1 and 10). 
The Devdopment  of Tolerance to Endogenous Pyrogen with Successive Injec- 
tions.--In  order  to  determine  whether  there  was  any development  of  teler- 
ance to repeated injections  of endogenous pyrogen, a  group of recipients  was 
given a  series of eight daily  inoculations  of 15 ml.  endogenous pyrogen. 
Since the responses of the group to this procedure were remarkably similar, ELISHA  ATKINS  AND  WEI  C.  H~ANG  427 
a  representative recipient has been selected.  The responses of this animal  on 
alternate days are plotted in Fig. 10 (lower shadowgraphs). 
The following features of developing tolerance to this dosage of endogenous 
pyrogen are particularly noteworthy: (a)  The absence of any consistent change 
in the onset, height or duration of the first peak; (b) The progressive depression, 
delay, and eventual disappearance of the second fever peak with a marked de- 
crease occurring  as early as the 2nd day. 
These characteristics of tolerance to endogenous pyrogen permit the follow- 
hag conclusions:  (a) No tolerance exists to the initial effect of injected endoge- 
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Fzo. 10. Febrile responses of representative normal recipients givea daily injections of 
either 1 ml. NDV or 15 ml. endogenous  pyrogen. 
nous pyrogen. (b) Tolerance develops to the production of endogenous pyrogen 
as evidenced by the disappearance of the second peak. 
The Relation of Tolerance to Dosage of either Virus or Endogenous Pyrogen.-- 
French  (17)  and  Wagner  (18)  have  shown that  tolerance to an injection of 
virus is closely related to the dosage of either homologous or heterologous virus 
given on the preceding day. A large dose of virus, though producing no greater 
fever, may completely block the pyrogenic response to a small dose the follow- 
ing day. Tolerance developing to daily injections of endogenous pyrogen, how- 
ever, has been shown to affect only the second peak which,  like fever due to 
virus, appears to be due to the release of endogenous pyrogen (9). The presum- 
ably direct action of endogenous pyrogen which causes the first peak should 
be unaffected, in contrast to the pyrogenic action of virus, by an abrupt reduc- 
tion in the dosage of injected endogenous pyrogen. 
In  the upper half  of Fig.  11  are shown the mean febrile responses  of two 428  PATIIOGEN'ESIS OF ]~-V~R. III 
groups of rabbits to an initia! injection of either 1 ml. or 4 ml.  of NDV followed 
on the next day by a second injection of 4 ml. and 1 nil. of NDV, respectively. 
Tolerance to the smaller dosage was complete when it followed the larger. Al- 
though the initial fevers produced by the 1 ml. and 4 ml. dosages were indis- 
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Fro. 11. Pyrogenic effect of change in dosage of either virus or endogenous pyrogen. In 
upper chart are mean fevers in 4 recipients given either 1 ml. or 4 ml. NDV followed by re- 
versal in dosage the next day. Shadowgraphs show average  pyrogenic  responses induced in 4 
normal recipients by endogenous  pymgen from donors receiving either I or 4 ml. virus. Lower 
chart records similar experiment with endogenous  pyrogen using 15 and 50 ml. dosages. Virus 
fevers represent average of 4 individual curves;  mean fevers of 3 recipients are shown with 
endogenous pyrogen. Ordinate is reduced to one-half scale shown in previous figures. EP, 
endogenous pyrogen. 
tinguishable,  the shadowgraphs indicate  that  there was a  greater amount of 
transferable endogenous pyrogen in the donors receiving the 4 ml. injection. 
The same experiment was then carried out with endogenous pyrogen. Three 
normal rabbits were first injected with  15 ml.  endogenous pyrogen and their 
temperatures recorded. The following day the dosage was increased to 50 ml. 
In another group of 3 recipients the order of injection was reversed, the larger 
dose being followed by the smaller. 
The results are plotted in the lower half of Fig. 11. In contrast to the results 
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second peak was abolished in the recipients receiving  the smaller dose of en- 
dogenous pyrogen after the larger. 
From these two experiments the following conclusions  can be drawn: 
(a) The first peak of fever produced by endogenous pyrogen, unlike that fol- 
lowing  the injection  of virus,  was not  influenced  by an  abrupt  decrease in 
dosage.  This  supports  the  concept  that  endogenous  pyrogen  has  an  initial 
direct action on the thermoregulatory center. 
(b) Tolerance occurred only when the febrile response normally required the 
production of endogenous pyrogen. This applies both to fever with virus and to 
the second fever peak induced by endogenous pyrogen. Tolerance in both in- 
stances, therefore, indicates the absence of endogenous pyrogen production. 
(c) The degree of tolerance is directly related to relative size of the initial 
and the second doses of either virus or endogenous pyrogen. These dosages, in 
turn, are directly proportional to the amount of endogenous pyrogen released in 
the recipients.  (See shadowgraphs and febrile responses  to endogenous pyrogen 
in Fig. 11.) 
In summary, the evidence suggests that tolerance,  or the absence of endoge- 
nous pyrogen production, bears a direct relationship to the amount of endoge- 
nous pyrogen mobilized, either by virus or by endogenous pyrogen itself, on the 
preceding day. 
Maintenance of Tolerance after Course of NDV or Endogenous Pyrogen.--As 
shown above, animals given daily injection of virus respond with progressively 
less fever and endogenous pyrogen production (Fig.  1). Two possibilities  were 
considered: the refractory state results from a depletion of endogenous pyrogen 
due to its prior release or, conversely, that circulating  endogenous pyrogen itself 
suppresses the further mobilization of this substance. 
A group of recipients was given a course of eight daily injections of 15 ml. 
endogenous pyrogen from NDV-inoculated donors. The responses of a  repre- 
sentative recipient have been shown in Fig. 10. It will be noted that the second 
peak, indicating activation of the recipient's endogenous pyrogen, did not per- 
sist beyond the 2nd day. However, when the 4 recipients were challenged  with 
a large dose of endogenous pyrogen (50 ml.)  on the 9th day, they all responded 
with monophasic fevers characteristic  of tolerance  (see  Figs.  5 and  10).  For 
comparison, the mean response of a group of normal recipients is shown to 50 
ml. endogenous pyrogen after a single iniection of 15 ml. endogenous pyrogen 
(Fig. 11). The presence in this latter group of a marked second peak indicating 
the release  of endogenous pyrogen to the larger  dosage is evident. 
A  course of injections of endogenous pyrogen thus appears more effective 
than a single injection in blocking the further activation of this substance, al- 
though there seems to be no more endogenous pyrogen released during a course 
than with a single injection (note absence of second fever peak from 3rd through 
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available endogenous pyrogen but that  circulating endogenous pyrogen itself 
may actually suppress the release of this substance to a subsequent pyrogenic 
stimulus. The evidence, however, at present does not permit a definite  conclu- 
sion on the mechanism by which endogenous pyrogen release induces tolerance. 
In an additional experiment, 4 recipients were given a course of eight daily 
injections of 1 ml. NDV. The development of tolerance is shown in the shadow- 
graph (Fig.  10). At the conclusion of the series, the 4 recipients were given 15 
ml. endogenous pyrogen. All the animals had monophasic responses  (see Fig. 6). 
The persistence of tolerance to endogenous pyrogen after daily injections of 
virus contrasts with the response of recipients rendered endotoxin-tolerant by 
a course of injections of typhoid vaccine. These recipients, when challenged with 
endogenous pyrogen, had normal biphasic fever curves indicating that tolerance 
to endogenous pyrogen had lapsed during the acquisition of tolerance to bac- 
terial pyrogens (see Fig. 6). 
DISCUSSION 
These experiments have tended to indicate a close relationship between the 
production of endogenous pyrogen and virus tolerance.  The decrease in fever 
to reinjected virus, characteristic of tolerance,  is associated with a comparable 
reduction in the level of circulating  transferable endogenous pyrogen. 
Correlated with the change which occurs in production of endogenous py- 
rogen to reinjected virus is the altered response of the virus-tolerant recipient 
to an injection of endogenous pyrogen itself. 
As shown in the preceding paper in this series, injected endogenous  pyrogen 
seems to cause the release of further endogenous pyrogen in the normal recipient 
with the development of a characteristic second peak of fever (9). However, the 
recipient given virus on the preceding day (and hence designated virus-tolerant) 
responds only to the direct pyrogenic action of injected endogenous pyrogen 
as evidenced by a monophasic rather than a biphasic fever. 
There appear to be two basic febrile responses to the injection of endogenous 
pyrogen: monophasic and biphasic.  All recipients which react with a biphasic 
fever curve also react normally to an injection of virus. These include the vari- 
ous types listed in Table H. None of these recipients has received an immediately 
preceding injection of a pyrogenic agent which releases  a  transferable amount 
of circulating endogenous pyrogen.  6 The endotoxin-tolerant recipient deserves 
special mention. Although daily injections of endotoxin are given up to the time 
of the experiment, clearance of exogenous pyrogen is so rapid that no detectable 
endogenous pyrogen is present in the sera of this group (2, 19, 20). On the other 
hand,  all  of the recipients which  have a  monophasic response  to endogenous 
pyrogen have had an injection of a pyrogenic agent on the preceding  day and 
s Fever accompanying the intramuscular injection of epinephrine is unassociated with a 
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also show some degree of tolerance to virus. The presence of a second fever peak 
to  injected  endogenous pyrogen appears,  therefore,  to be a  measure  of the 
recipient's ability to produce endogenous pyrogen which also seems to be essen- 
tial for the normal febrile response to virus. Similarly,  tolerance to endogenous 
pyrogen, characterized by absence of a second fever peak, may be equated with 
tolerance to virus since  in both instances there is a  reduction or absence of 
endogenous pyrogen production. From the observed differences in the response 
of normal and virus-tolerant recipients to an injection of endogenous pyrogen, 
it is postulated that the circulation  of endogenous pyrogen on the previous day has 
rendered the recipient  unable  to mobilize  its own endogowus pyrogen  and hence 
tolerant to an injection of either endogenous pyrogen or ~irus on the following day. 
The normal recipient also develops tolerance to daily injections of endoge- 
nous pyrogen as indicated by the gradual disappearance  of the second fever 
peak. However, there is no change in either onset or height of the first fever 
peak with continued injections of endogenous pyrogen (Fig.  10). e The absence 
of tolerance to the direct pyrogenic effect of endogenous pyrogen would appear 
to rule out the participation of the thermoregulatory center in the development 
of tolerance. 
Virus,  on the other hand, seems to cause fever only indirectly by the libera- 
tion of endogenous pyrogen in the recipient,  as indicated by the long latent 
period. Accordingly,  with successive  daily injections of virus,  there is a  pro- 
gressive reduction in the height of the first as well as the second peak consistent 
with a demonstrable decrease in the production of endogenous pyrogen (Fig. 10). 
Tolerance to the pyrogenic effect of virus, therefore,  involves both fever peaks 
and  apparently results from mechanisms  which  interfere with the release  of 
endogenous pyrogen. The mechanisms  seem to be similar  to those operative in 
the development of tolerance to endogenous pyrogen itself. 
The foregoing experiments have defined four distinct categories of tolerance: 
(a)  Cross-tolerance  between two different  exogenous  pyrogens: virus  and 
endotoxin;  ~ (b) Tolerance to endogenous pyrogen (absence of second fever peak) 
after  preceding  injection  of homologous  or heterologous exogenous  pyrogen 
(virus or endotoxin); (c) Tolerance to exogenous pyrogen (virus)  after a large 
injection of endogenous pyrogen; (d)  Tolerance  to  endogenous pyrogen (loss 
of second fever peak only) developing with daily injections. 
6 A .~imilar type of tolerance seems to develop with the daily injection of canine granulocytic 
exudates in dogs (21,  see shadowgraphs). 
In retrospect, it seems not unlikely that the effectiveness of crude Cholera vibrio extract 
in conferring tolerance to the pyrogenic effects of a subsequent injection of influenzal viruses 
(22) may have been due to an endotoxin present in this material. It is not stated whether fevers 
were obtained with the extract, although its toxicity is evident by the fact that approximately 
one-fourth of the animals died. In this regard, it has been shown recently that the intravenous 
injection of endotoxin is capable of inducing tolerance to the toxic effects of influenza virus 
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It is postulated that all of the changes described above may be actually due 
to the last mechanism. The injection of a number of pyrogenic agents including 
endogenous pyrogen itself, seems to be followed by the release  of a detectable 
amount  of  endogenous  pyrogen  in  the  recipient.  This  latter  reaction  then 
appears to induce a temporary and relative refractoriness to further endogenous 
pyrogen release  which is characteristic of tolerance to both virus and endoge- 
nous pyrogen. The similar  duration of tolerance to small amounts of virus and 
endogenous pyrogen is  also  suggestive of  a  common underlying  process.  Of 
interest in this regard are the results with antipyrine.  Abolition of virus fever 
with antipyrine does not prevent the development of tolerance either to virus 
(7)  or to injected endogenous pyrogen (9).  The hypothesis that  endogenous 
pyrogen is itself important in the development of tolerance to these agents is 
strengthened  by the additional findings  that antipyrine does not modify the 
appearance of circulating endogenous pyrogen following an injection of virus (8). 
Conversely, procedures which render virus non-pyrogenic (e.g. heating or incu- 
bation with homologous immune serum) also make virus incapable of inducing 
tolerance (7,  17) suggesting  again that tolerance is dependent  upon the prior 
release of endogenous pyrogen. 
Certain differences should be pointed out between the type of tolerance de- 
scribed here and that which develops with successive injections of endotoxins. 
Studies  of the "clearance" of intravenously injected PR8 virus in normal and 
virus-tolerant  rabbits show identical values despite the  absence of  transfer- 
able endogenous pyrogen in the circulation of the tolerant animal. 
This  finding  contrasts sharply  with  the  situation  existing  in  tolerance  to 
bacterial pyrogens, in which the development of an accelerated clearance  of in- 
jected endotoxin appears to play a major role  in the pathogenesis of tolerance 
(2,  19, 20, 24-26).  8 Furthermore,  the reversal of tolerance to endotoxins but 
not to PR8 virus with the so called reticuloendothelial blocking agent, thorotrast 
(7), is consistent with the concept that pyrogen tolerance  is largely due to an 
enhanced removal of endotoxins by cells of the reticuloendothelial system. 
It should be emphasized,  however, that there is a decrease in the detectable 
level of endogenous pyrogen in both these forms of tolerance.  With endotoxins, 
the acceleration of clearance apparently results in a  correspondingly diminished 
stimulus  to endogenous pyrogen production. Since relatively little endogenous 
pyrogen has been mobilized,  the pyrogen-tolerant recipient has available sup- 
plies and therefore responds like a "rested" or normal recipient to the injection 
of either virus (7) or endogenous pyrogen. The virus-tolerant  recipient, on the 
other hand, seems to be unable to respond normally either to endogenous pyro- 
gen  or  reinjection  of virus  because  the  previous production  of  endogenous 
s With certain endotoxins, however, the onset of tolerance occurs as early as the 2nd day 
with disappearance of the second fever peak (5). Since the phagocytic function of the reticulo- 
endothelial system is actually depressed at this time (25, 27, 28), this type of early tolerance 
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pyrogen has resulted in a temporary impairment of its ability to release further 
amounts of this material. 
The diminution in the febrile response,  characteristic of both forms of toler- 
ance, appears to be a result of the decrease in endogenous pyrogen production 
although the mechanism of this decrease is different in the two situations. 
Although the source and intermediate events in the liberation of endogenous 
pyrogen  remain  unknown,  the  particular  types  of cross-tolerance  demon- 
strated  here between virus and  endotoxin suggest  that  endogenous  pyrogen 
circulating in these two types of fever may be similar.  Furthermore,  the fact 
that  both  viral  and  vaccine-induced endogenous pyrogen produce an  equal 
degree of fever in normal and endotoxin-tolerant animals (20, 29, 30) indicates a 
similarity  to leukocytic pyrogen (31) and,  conversely, would seem additional 
evidence that  these substances are not identical with known pyrogenic poly- 
saccharides of either bacterial or tissue origin  (32), 
SUMMARY 
Tolerance to the pyrogenic action of intravenously injected virus has been 
studied in rabbits given either PR8 strain  of influenza  A virus or Newcastle 
disease virus (NDV). The following findings  suggest that the capacity of the 
animal to release an endogenous  pyrogen is a critical  factor. 
(a) Viruses produce fever by the release of endogenous pyrogen. 
(b) Tolerance  to the pyrogenic effect of reinjected virus is associated with 
a decrease or absence of endogenous pyrogen production. 
(c) Tolerance to virus fever may be induced by the prior injection of endoge- 
nous pyrogen. 
(d)  Cross-tolerance  has  been  demonstrated  between  virus  and  bacterial 
endotoxin  (typhoid vaccine), both of which cause the release  of endogenous 
pyrogen. 
A difference has been noted in the mechanism of tolerance to successive in- 
jections of virus and of bacterial endotoxin. Repeated injections of endotoxins 
bring about an accelerated clearance of these substances from the blood stream 
with the result that there is a diminished  stimulus to endogenous pyrogen pro- 
duction: Tolerance to virus, on the other hand, is unaccompanied by changes 
in the rate at which virus disappears from the circulation.  It is postulated that 
circulating endogenous pyrogen, induced by the injection of a number of pyro- 
genic  agents  including  viruses,  temporarily suppresses the further  release  of 
endogenous pyrogen and thereby contributes to virus tolerance. 
The authors wish to acknowledge their indebtedness to Dr. P. B. Beeson for many helpful 
suggestions in the preparation of these three papers. 
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